SPOTLIGHT -
Exploring Ongoing Trials With 177Lu-PSMA-617 in Prostate Cancer
Arun Azad, MBBS, PhD, discusses ongoing studies of lutetium-177-PSMA radionuclide in patients with prostate cancer.